Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors.
Jasmine M CrossTim R BlowerNatalie GallagherJason H GillKimberly L RockleyJames W WaltonPublished in: ChemPlusChem (2016)
The first examples of RuII and RhIII piano-stool complex histone deacetylase (HDAC) inhibitors are presented. The novel complexes have antiproliferative activity against H460 non-small-cell lung carcinoma cells that is comparable to the clinically used HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). Strong evidence for HDAC inhibition as a primary mechanism of action is provided. The complexes reported here represent an important step towards the design of highly active and selective HDAC inhibitors.